Telix Pharmaceuticals 1H25 NPAT up 860% to $49.9m, FY25 revenue guidance of $1.18-1.23bn vs. $1.02bn consensus, R&D ...

ANALYSISThe Reserve Bank of Australia could still have a whole bag full of rate cuts to dole out in 2025, according to a new analysis that has major implications for the housing market.

Many investors have no idea the huge lithium demand wave that potentially lies ahead. The article lists our top ten lithium ...

The Australian share market has ended lower on Wednesday, a day after the RBA delivered a long-awaited rate cut, while wages ...

The Nifty index opened flat, and witnessed selling pressure in the first half, but saw a sharp recovery in the second half, ...

The rate cut will provide some relief to borrowers and comes as good news for Prime Minister Anthony Albanese, who is facing a tough election to be held no later than May 17.

European leaders hastily gathered in Paris to discuss Ukraine peace plans. Defense stocks jumped after EU members were ...

This ASX 200 index forecast explains what to expect now that the Reserve Bank of Australia (RBA) has started to cut rates ...

These three premier ASX healthcare stocks just reported half-yearly earnings – and each saw its share price dip…So, is now the time to buy?

The first of Opthea’s (ASX:OPT) two phase III eye disease trials has hit a key development milestone, with the last patient ...

Exchange traded funds (“ETFs”) continue to rise in popularity with over half of Australian investors now holding at least one ...

However, the S&P 500 ( ^GSPC 0.24%) is generally considered the best barometer for the overall U.S. stock market due to its ...